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frequently , thus prolonging his mother's natural infertility and ~tponing 
the arrival of the sibling who will displace him from his mot! s arms); 
that babies come more frequently (I Y2 to 2 Y2 years) when p; ;ts enjoy 
the energy of youth and less often (2 to 3 years or more) as r nts enter 
their late twenties and thirties ; that with natural child-spal 
breastfeeding, the inherent infertility of the human species w< 
average family size to about four or five well-spaced childre1 
14-child families of a generation ago were usually associate( 
feeding). We say these things not as preachers , moralists , o 
but merely as physicians who care for our patients in thei t 
In this way, we bring to bear on the solution of practica; 
the lives of our patients our special knowledge, which is gr 
Church's teaching on the inherent benignity and universal u 
human behavior of the natural law and , with God's help , we 1 
from self-destructive decisions. 
There are so many other areas of medical practice whic: 
enlightened by our faith: the care of the elderly, of the dying, < 
newborns, of infertile couples. In all these cases , the seemi; 
teachings of the Church actually liberates us and our patient 
humane solutions to difficult problems. Only by heeding th 
which, like warning labels , keep us from administering h ~ 1 
can we truly be healers - givers of wholeness - to our 
through 
keep the 
1e 12 and 
th bottle· 
mfessors. 
a! being . 
blems in 
J ed in the 
cability to 
save them 
1n truly be 
.mdicapped 
restrictive 
, seek more 
restrictions 
·ul poisons. 
1ents. 
Such a mission is impossible to each of us alone . We cann 
of what is truly good or harmful , of why it is so , and of how ' 
our knowledge effectively to our patients, without the inst n 
and encouragement of our fellow Christian and Catholic p 
is the raison d 'etre of the Catholic Physicians ' Guilds and 
Federation. 
1ow enough 
;)mmunicate 
Jn, counsel. 
,1cians . This 
the National 
If you have a local guild , be active; if not , start one . To, 1tt le interest? 
How many members does it take? ' 'Wherever two or three · 1 _1:athered._ · · 
Read this journal; discuss it with your friends. Come to one ,_, f the nauona: 
meetings of the Federation held each fall at various sites. For Ule past sev~ra 
years , these meetings have been uniformly superb - nourish. ; for the mmd. 
the emotions, the spirit. 
" Pray always ." 
W 'll' G White M.D. 
- 1 .am . ' 
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The Pill and Cancer 
Kevin Hume 
a Doc~or Hume, an Australian physician , prepared the following paper for 
A seml~ar on family planning at the Academy of Science, Canberra , 
ustralwn Capaol Territory , in November , 1983, and updated it this past 
summer for b!' · · L · h pu tcatwn 111 macre Quarterly. He notes that the three studies ~ 1 ~end of the paper, from the Centres for Disease Control Cancer and ,::~~ f!ormone s:udy are of particular interest to U.S. readers. They were 
su a~lable until after the paper was completed, so Doctor · Hwne 
mmanzed them as they are presented here. 
The DES Problem 
Diethylstilbestrol, although a synthetic estrogen, is not a steroid and has :t~ncy only 1/_25 that of ethinyl estradiol, the estrogen most commonly 
DES ~n the combmed estrogen-progestogen Pill. Nevertheless the story of 
of or~~ very relev~nt in any examin~tion of the subject of the relationship 
The c~:t~acept1~es and neoplast~c changes in women. 
Puen R' bl_ned Pill _ was launched m 1958 after very inadequate trials in 
and ;r ICO 10 ~h~ m1~ 1950s and was given limited approval by the Food 
lllainl ug AdmmlstratJOn (FDA) of the U.S. in 1960. The drug company 
at Y responsible for its early promotion. G. D. Searle and Co .. conducted 
remendous ad t . . . the p- 11 . ver 1smg promotiOn campaign and very soon women on 
PFess 
1 10 the U.S. were being numbered in millions . This put indirect 
ure on the FDA h · h h h tas re 1 w IC • w en t e extent of the thalidomide disaster Ciutionve~ ed by the find~ngs of McBride in 1961, should have called for 
the Fa ·.1 owev~r, the Pill got the green light and , on the reassurance of in 19()~1 §.Plannmg Association that it was safe, was introduced into Britain 
Pili, eac.h mce t~en we have seen a succession of new formulations of the Thedotoclalm~d to b~ "safe" and indeed "safer" than its pr~decessor. 
onty a f e_of the mgred1ents has been progressively lowered till it is now ~._ ractlon of what .t . h . . I . 
'lil\'e qu· 1 . 
1 was m t e ongma Pill. Some of the ingredients forrnulat:~~~ dlsappea~ed ~!together, as have the so-called sequential 
COurse, is th · much ~all~d m the late '60s and early '70s . The. reason, of 
at the Pill, m practice, was shown to be not so safe . While 
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increasing animal experimentation was carried out to test n·. 
real guinea pigs have always been the actual users, the won 
Generally speaking, the victims have been young, healthy W< 
needless to say, the casualty rate rose sharply in the ol? 
The DES experience was very similar. However, a~ ~t 
there has been more time to see the long term results, giVII 
of things to come. DES was first synthesiz~d ?Y Dodds ar 
1938. Its most prominent use followed studies 10 1948 and 
who suggested that DES was benefici~l in ~oth t~e treatmC' 
abortions and the prevention of abortions 10 patients whc 
had repeated pregnancy losses. Between the late 1940s and I 1 
two to three million women (mostly in the U.S.) , were prescr 
their pregnancies , thereby exposing I to 1.5 million fetus, 
the drug. Later studies showed that DES was not ?nl~ 
benefitting women suffering from the disord~rs for wh~ch I ' 
but was actually associated with significant mcreases 10 ar 
deaths and premature births. In addition, serious long ter 
of in utero exposure to DES have continued to come to 
In 1970, Herbst and Scully reponed the occurren< 
adenocarcinoma of the vagina in seven girls, aged 14 to 
seven cases exceeded the total ~f all previously reporte 
this age range. In 1971 , an epidemiologic study demom.! 
vaginal clear cell adenocarcinoma to in utero DES exp• 
occurred 15 to 20 years earlier. The FDA banned the 
pregnancy the same year. However, the legacy of in ute r 
eroids, the 
1emselves. 
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,Jleagues in 
..) by Smith, 
f threatened 
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an estimated 
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each sex to 
uccessful in 
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n, neonatal 
on sequence 
1t. 
(l f clear cell 
years. The~e 
.:h cancers JO 
~d the link of 
re which had 
,e of DES in 
u ES exposure 
has continued to grow. has been 
Although the most serious side effect to DES-exposed d;, ..!hte rs ch 
the induction of neoplasia (with over 300 cases reported L•. to 1979), sune 
· 1 and uten daughters are also more likely to have m10or vag 11 ·1 
1
. . of 
abnormalities. Their fertility is affected resulting from -thnorma ltle\ al 
. . I f~ ·t . and cervl anatomical development with cerv1ca mucus c el ' F II pian 
incompetence, as well as structural abnormalities of the u terus and_ : r~lit . 
tubes, leading to menstrual and reproductive dysfunction . e. g.~~" :rinatal 
spontaneous abortion, ectopic pregnancy, premature del l\ cry a P 
death. . However 
In male progeny there has so far been no evidence of malignancy· ·tal ia 
I. · f the gem there have been structural developmental abnorma 1t1e~ 0 nded 
. . . d d d I d and undesce affecting the pems, ep1d1dymal cysts an un er eve ope 
testes. t f h developmenl 
The maior risk of DES exposure may turn out to be not o t. e 
0100 :.~ · 1 d v1cal squa of clear cell adenocarcinoma, but of vagma an cer dl 
2 
1 \t . 
f I · · h s is reporte Y · metaplasia . The prevalence o dysp as1a 10 sue case ·noma· 
. . h . 'd ce of carcl whereas there is an esti_m_a~ed five-fold ~~crease 10 _t e_mcl en . malignanCY· 
in-situ. with the possibility of a vast mcrease 10 squamous DES a a 
A case of a 23-year-old single woman. who was exposed 10 ted with 
fetus and affected by cervico-vaginal adenosis and as a result presen 
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~arc • noma-in-situ, was reported by Shepherd, Dewhurst and Pryse-Davies 
m the British Medical Journal. 2 Of particular interest was the fact that she 
was taking the Pill, resulting, in her case, in double exposure to estrogens, 
albe:t 24 years apart. 
At this time , there is no substantial evidence that DES taken during the 
pregnancy has had an adverse effect on the health of the mother. However, 
the well known epidemiologist, Dr. Valerie Beral and Linda Colwell , 
reported a link ·between the taking of DES during pregnancy and the 
appearance 18 to 22 years later of breast cancer. 3 It is recommended that 
women who have taken DES in pregnancy be subjected to regular breast . 
checks and Pap smears associated with colposcopy. 
. There have now been seven patients with vaginal clear cell cancer ~Jsco~ered in Australia ; six of these patients had a history of maternal 
mgest10n of DES. In 1972 , the Me,dical Journal of Australia published a 
statement from the Australian Drug Evaluation Committee outlining the 
danger of maternal DES therapy and also the risk of the DES content of 
the "m~rning after" Pill. DES Referral Centres have been set up in Australia 
-at Prmce Henry' s Hospital in Victori a and King George V Hospital for 
Mothers and Babies in Sydney . 
A_ recent study by Greenberg et al, supported by a grant from the US 
NatiOnal Cancer Institute, compared the incidence of breast cancer in 3 ,033 
women ~ho had taken DES in pregnancy during the period from 1940 to 1960, With the incidence in a comparable group of unexposed parous Yiornen.~ They found a crude relative risk of 1.4 in the exposed group, which 
had a slightly higher breast cancer mortality (relative risk 1.1) than in the 
unexposed. The authors concluded that the incidence of breast cancer was 
:erately but statistically s ignificantly ~n~~eased in women given DES , we~e unable to exclude the poss1bll1ty that some unrecognized 
COncomitant of DES exposure accounted for this increase . 
The findings of this study showed that DES-exposed women clearly 
:ared_to be at an increased risk of breast cancer which, while less than 
llore assac1ated with a_ pos!tive family history of the disease , seemed to become 
6lu pronounced With time and may prove to be of greater concern in the ~: The frequency of breast cancer among the controls in this study 
-"''Pt!d after the age of 60 years, when the difference between exposed 
unexposed women was most pronounced . 
The long-term effects of DES exposure on mothers. daughters and sons ~ kno~n and there is a continuing need for well-documented and Jong-
ng studies to identity new problems and increased health risks associated 
exposure to DES , as well as to allay anxiety among DES-exposed 
ns and their families. 
one recent study, Depue et al noted that testicular cancer was more 
nt _among males with intra-uterine hormone exposure (9 of I 06 patients 
testicular cancer vs . 2 of 107 controls had been exposed to hormones). 
ver, in this series, five of the nine exposed mothers had received oral 
ne pregnancy tests and only two had taken DES . 5 
' 1985 
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Endometrial Cancer - The Oracon Story 
The incidence of cancer of the endometrium in women ~el ( 
of 50 years is quite low at 14 cases per 100,000 women. It IS r 
rare in this age group where there are normal .regul~r menstJ 
Those at special risk are the obese and the mf~rtJ!e and ~ 
polycystic ovarian syndrome and in women. havmg est.roge .. 
tumors and failure of ovulation and dysfunctional ble~dm~ . 
conditions produce a situation where the endometnum IS 
prolonged stimulation by estrogen unopposed ?Y progesterc:-
the age 
icularly 
, cycles. 
cially in 
mducing 
of these 
posed to 
rna have 
Jn in their 
nenorrhea 
frequently 
ne triad of 
~ ients with 
Women who ultimately develop endometnal ~denocaJ . 
frequently shown signs of hypothala~c-pituitary-ovanan dysfi , 
reproductive years, manifested as ohgomenorrh~a, hyper- or h 
and polymenorrhea. These dysfunctional bleedmg p~ttern~ ?l 
because of failure to ovulate, causing problems of mf~rtJh.t~ 
hypertension , obesity and diabetes is a common findmg H 
endometrial cancer. 7 , 
Estrogen, whether endogenous or ex~g~nous. may, ove. 
of time, produce endometrial hyperplasia If not mterruptet· 
rogesterone. This entity has been shown to advance . t 
hyperplasia, carcinoma-in-situ or eventually~ endo~etn~ . 
menopausal estrogen use has also been associated with tl , 
endometrial carcinoma. The overall risk has been shown 1 
estrogen users as opposed to non-users. Long-term use o 
carries a 15-fold risk. . ~ 
ong period 
opposed by 
Jenomatous 
,ncer . Post-
:currence of 
. six-fold for 
cr five years 
In 1963' sequential oral contraceptives were fi~st mar 
Their use was promoted , in part, by an effort to Simulat~ 
natural sequence of estrogen , followed by estrog~n-prog 
1 during the normal menstrual cycle. The scheme mvol vec 
meg. of estrogen alone for 14 to. 16 days , followe~. 
progestogen combination for five to SIX days, the progestoc 
J in the U.S. 
re clearly the 
one, as found 
'-. ing 80 to 100 
an estrogen-
·ontent varying 
from as little as 3mg to 25mg. s . t !he occurrence 
Silverberg, Makow~ki and ~yon, m 1975 , first re~o: . -,equential oral 
of endometrial carcmoma m young women ta f ·thers By June, 
contraceptives. These reports were qu~ckly followed ~) .' ~triu~ had been 
1976 30 cases of verified invasive carcmoma of the en c'1'1d documented 
' d h f 40 who ha a identified, occurring in women un er t e age o used sequential type 
history of oral contraceptive use. Twenty ~ad d one patient used 
preparations, nine had used combined form.ulatJOns, ~~i als had used one 
an unknown type. Nineteen of the ~0 usmg ~eque he .estrogen and 25 
preparation containing 100 meg of ethmylestradJOI ~~~ted under the tra?e 
mg of dimethisterone, a weak progestogen, and rna . d t the sequential 
name of Oracon. Before further studies could be carne ohu 'market by the 
·1 · hd n from t e oral contraceptives were voluntan y wit raw . 
f 9 . d metnal manu acturers. b . d. sites m the en ° Progesterone competes with estrogen for m mg 
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cells and may reduce the estrogen-stimulating effect. The exposure of the 
normal estrogen-primed endometrium to progesterone converts this tissue 
to the typical secretory type seen during the luteal phase of the menstrual 
cycle. This cyclic effect of progesterone prevents the normal proliferative 
endometrium from progression to hyperplasia. The addition of a potent 
progestogen to the estrogen produces a decidual pattern of endometrial 
response with a tendency to atrophy rather than progress to hyperplasia . 
This property of progestogens is used therapeutically in the treatment of 
endometrial cancer, which , incidentally , has a good prognosis with a cure 
rate of 90%. Depo-Provera, (Medroxyprogesterone acetate) , in large and 
repeated doses , appears to be the drug of choice. 
However, predictions that the simultaneous administration of estrogen 
and progestogen might reduce endometrial cancer risk should be regarded 
with caution. While they do reduce the incidence of endometrial hyperplasia, 
there is no direct evidence that this applies to endometrial cancer as well. 10 
All estrogens seem to increase endometrial cancer risk, irrespective of 
their formulation or mode of administration. Initially it was thought that 
conjugated or "natural'' estrogens , particularly estrone, were primarily 
responsible for the association , but recent work has implicated synthetic 
compounds such as DES as well. Similarly it was thought earlier that 
estrogens were more hazardous when given continuously rather than 
cyclically, but this, too, is unsupported by newer investigations. 11 
The addition of a powerful progestogen may protect women in older age 
groups who take estrogen for prevention of osteoporosis or prolongation 
of the "youthful look" , but it introduces all the hazards of thrombo-em~lism, hypertension and myocardial infarction which characterize the 
taking of the Pill by women in older age groups. The mortality rate 
accompanying Pill use in this group is 22 per 100,000 wome.n and this 
exceeds that of endometrial cancer by far. 12 
The Pill and Breast Cancer 
of In .1950, a trial was set up in England to evaluate the effects of large doses 
. stilbestrol (DES) and ethisterone , a progestogen , on rates of fetal loss 10 P~egnant diabetic women. Eight women were allocated at random to 
l'eceJve the hormonal treatment and 76 to receive inactive tablets. The aim 
:;s to. establish the efficacy of this treatment in reducing fetal loss , the rates 
Wh1ch Were exceptionally high in diabetic women. Identical rates of 
tmtaneous abortion (8%) and perinatal mortality (23 %) were noted in both 
fi honnone and non-hormone treated groups. Similar results were obtained ~non-diabetic women in a randomized trial of stilbestrol conducted in ~go. Tha~ both studies failed to show a beneficial effect of hormonal 
honn ent dunng pregnancy did much to curb the administration of sex l9fios~nes to pregnant women , although the practice continued during the 
' 1985 
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In 1978, Bibbo and colleagues reported the results of the 25- ::. 
up of the mothers who had participated in the Chicago-based 
found an excess of breast cancer in the group treated with stilbest: 
the difference was not statistically significant. 13 
In 1980, Valerie Beral and Linda Colwell , who was involved i• 
English trial , reported on the long term follow up of mothers 'A-
Information about all but four of the women was obtained (97 %, 
mortality was 4 .5 times that of comparable women in Englan 
most deaths being from complications of diabetes. More tu, 
benign , were reported in the hormone-exposed than the non-e 
(14-18% and 2-3 % respectively). Four cases of malignant 1 
were reported in the hormone-exposed women and none in thC' 
Beral and Colwell concluded that these findings supported c 
linking estrogen treatment and breast cancer and suggested 
period before the tumor becomes clinically apparent may 1 
longer . 
· follow-
11. They 
although 
;: original 
ok part. 
1e overall 
1d Wales, 
s , mostly 
sed group 
st disease 
t-exposed. 
r evidence 
the latent 
5 years or 
In a commentary on the findings of Beral and Colw 
Millington drew attention to the fact that most studies on oral 
found no increase in breast cancer in Pill users and perhaps, e 
However, they pointed out that a delayed appearance of bre3 
as that noted byBeral and Colwell , might have been missed b 
women predominated in these investigations . They were pror 
these studies and prepared a table summarizing data from f1 
studies of breast cancer according to "young" and "old " ~ 
categories differ among studies and for two studies , the) 
premenopausal patients were younger than postmenopau 
Vance and 
\traceptives 
a decrease. 
ancer, such 
use younger 
~d to review 
._:ase-control 
,; roups. Age 
1 esumed that 
I -I 
The data in their table indicate an increased risk of brea• 
women with a positive history of oral contraceptive use, bu 
have passed into their fifth or sixth decade. Most Pill usl 
reached the critical age. 
ancer among 
.nly after they 
have not yet 
Relative Risk of Breast Cancer in Women with a · Iistory of 
Contraceptive Use Compared with Controls in Publi.., hed Studies. 
Definition (y) No. of cases Rela tive risk 
Reference Young Old Young Old Young O ld oc use 
-
1 15-39 40-49 104 348 0.72 1. 3 1 Ever 
2 pre post 126 160 0 .80 1.66 Ever 
3 16-40 46-50 301 115 0.8 2.4 Ever 
4 pre post 768 1090 1.09 1.24 Ever 
5 31-45 46-55 31 24 1. 2 3 .2 Past 
5 31-45 46-55 23 26 0 .8 8.0 Present 
--
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~reast cancer is more common among women who have never borne 
children than among parous. women and the longer a woman delays her first 
pregnancy; the more she mcreases her risk of developing the disease 
Recently, It has been suggested that prolonged use of oral contraceptive~ 
before the first ~ull-term pregnancy may increase the risk of breast cancer 
although after thts pregnancy the risk is probably unaffected by taking the Pill: 
. Clearly , the first full-term pregnancy does something to alter a woman ' s ~tsk of developing breast cancer. Whether or not she breastfeeds is probably 
I~elevant, but there is good evidence that the breast epithelium is permanently 
changed .by pr.egnancy. Although histological change occurs in the ductules 
t ehphysiOlog.tcal change in the epithelium, shown by its altered respons~ t~ 1ormones , IS more striking. Possibly the high progesterone concentrations 0 ~te pregnancy induce progesterone receptors which can then respond 
:
1
. e lower concentrations of a normal menst rual cycle. If these receptors 
the madequa~e before the first full tetm pregnancy ' then during normal cycles 
e breast wtll therefore be exposed to " unopposed " estrogen despite th~ 
presence of nor 1 · . ' The rna co.ncentratiOns. of progesterone m the circulation. Is 
w effe~ts of the .Pill may be dtfferent among nulliparous and parous 
1~men ~~ Is n~w bemg suggested by epidemiological surveys. Although 
Of thcom t~ed Pill provides estrogen balanced by progesterone if the breast e nulltparous ' 
the woman cannot respond to the progesterone component n a young g · I t k' h p · · · ' 
"uno 
0 
, tr a mg t e til IS exposmg her breast epithelium to 
Ea P1P sed estrogen , although in a low , but steady concentration r Y men h 11· · ' · fact . arc e, nu tpanty and late menopause are also important risk 
beg?rs Ihn the development of cancer of the breast . The sooner the cycles 
In, t e sooner the " d" · 
epithel' 1 unoppose estrogen begms to act on the breast cycle mm_ . n the p~emenopause, there is an increased frequency of anovular 
asy ts, agam exposmg the breast to " unopposed" estrogen. A further but 
e unconfirmed · k " · h · · · . ' 
n .... 1 · ns tactor , IS t at tdenttfied by Prke and colleagues 
..... ue Y an early · · b ' rnn~ . . ffiJScarnage efore the first full-term pregnancy . Although 
:-"''cntrattons of both t d . . 
In the nulli es rogen an progesteron~ mcrease m early pregnancy ' 
having first~~;ous w~.man only the. estrogen wtll .affect the breast. Women 
Were shown mester. m?uced abo~JOns ~efore their first full term pregnancy . 
In the R.C.to be stmtlarly at ~I sk~ ~~th a .2.4-fold increas~.16 
to breast can G.P. study of the ~Ill, Initiated m 1968 , the findmgs in regard 
of breast cer were reported 1n 1981 . 17 One hundred thirty-three cases 
of the p·ucancer w.ere recorded . There were 19 deaths among ever-users 
in the in 
1 
.d and IO m the controls. Analysis showed a significant increase 
if they h~d e:e of breast ca~cer among women aged 30 to 34 at diagnosis 
- 6ll w er used the Pill. By 1979 , less than 5 % of the original 23 
for how ;men- were current , if intermittent users. No figures are given 
or had us~n\of t~e 18 ,755 women , enrolled when they were already using 
llseof the p ·ut e Pill , had developed breast disease during their previous 
This previo~s' thought to amount to 25,570 women years (R .C.G.P. 1974) _ 
been obser du.se was excluded from the final analysis because it had not 
ve tn use. 
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In 1981 , Pike et al collected records of 293 women with b1 
under the age of 33 between 1972 and 1978; 48 had died an< 
interviewed, 83% had used the Pill. Those who had taken it 
first full-term pregnancy had an increased risk which rose with 
of Pill use. 18 In 1977 , Passenbarger et al found that 15 out l 
under the age of 30 with breast cancer had used the Pill. 19 
Pike also found a significant increase in breast cancer in 
a history of benign breast disease. Hoover eta! , in 1976, fou nc 
use was related to an especially high risk of breast cancer if the 
developed after the women had started the drug. 20 The fi1 
epidemiological trials that the Pill reduced benign breast dise 
seemed anomalous to some clinicians whose observations s 
.; t cancer 
r' the 163 
fore their 
: duration 
5 women 
•men with 
tt estrogen 
ign disease 
.g of large 
opposite. 21 · 
The study of Pike et al gave rise to extensive corresponden 
Medical Journal , especially challenging their concept of the 
of oral contraceptives according to "progestogen potency" 
is typical. However Swyer said: "My competence in epi 
not allow me to criticize the general contention by Pike et < 
use of oral contraceptives by young women may increase t 
cancer . . . " 22 
Meanwhile, the FDA, having reconsidered its posi 
contraceptives and cancer, made a firm statement that the1 
risk of breast cancer in oral contraceptive users of an: 
association with any particular formulation of oral cont· 
as always 
ved just the 
1 the British 
lassification 
tat of Swyer 
liology does 
at long-term 
isk of breast 
t about oral 
no increased 
.1tegory or in 
: ptives. 
;sor Vessey's 
1traceptives to 
increased risk 
However the FDA felt somewhat uneasy about Pn 
findings. It was planning to revise the labeling of oral 
include a warning that their use may be associated with 
of cervical cancer. 23 
More recently , a group of Swedish researchers has al! :l its su~p~rt to 
the findings of Professor Pike and his Los Angeles grou: n a prehmwar~ 
report of a study about to be published. A case control ,.: dy was done 0d 
80 consecutive cases of breast ca~cer in women. born .ir • : 39 or lat~~ a~y 
diagnosed at the age of 45 or ear her, who were mterv1e , d persona Y 
their physician. These were matched with 225 control' . 0 
d. . 1 1 · .. · c regress1o ' When the data were analyzed by con Itwna ogandl ml . es 
women who had started to use the Pill at 20-24 years of age had three;n~th 
the risk of developing breast cancer prior to 46 years of age compare WI 
non-users . . . . . . . p·Jl wornen 
The relative nsk mcreased with earher age of startmg the 1 · . risk 
beginning to use the Pill after their first preg?a~cy had a lo~e~rel:!;v;tion , 
than others, although the difference was not sigmficant . In thts wv:ncg were 
both a low age at menarche and a high age at first full -term pregn Y 
related to increased breast cancer risk. . ier reports 
The authors conclude: "Our results, taken together wtth earl ncern 
linking early O .C . use with breast cancer, are a matter of great co 
in respect of 0. C. use by young women''. 24 
The Pill and Liver Tumors 
The association between taking the Pill and the development of non-
malignant liver tumor hepatoma was first suggested in 1972 by Horvath. 25 
The following year , Baum et al described seven women , all oral contraceptive 
users, who developed benign hepatic adenomas . 26 Subsequently a number 
of reports have appeared supporting these findings , although the 
histopathologic . diagnosis has been variously reported as ·focal nodular 
hyperplasia, adenoma, hamartoma, benign hepatoma, solitary hyperplastic 
nodule and focal cirrhosis. Prior to 1970, benign liver tumors in young 
women were very rare. 
Th~ risk of developing these liver conditions increases dramatically with 
duratiOn of use of the Pill , particularly after 5 years. The majority of affected 
women had been taking mestranol-containing compounds , mestranol being 
a. sy~thetic estrogen metabolized in the body to ethinylestradiol. Nevertheless 
stg?Ificant numbers of these lesions have been reported in patients taking 
etht~ylestradiol-containing compounds. A few patients have taken DES, 
conJu~ated equine (natural) estrogens and progestogen-only compounds . 
Bemgn hepatoma is a very vascular tumor ?- 'ld subject to spontaneous 
rupture, death often resulting from massive hemorrhage. A carefully 
conduc~~ national survey , carried out by the American College of Surgeons ' 
CommiSSion on Cancer , showed the frequency of benign lesions indicated 
~large peak in the 26 to 30-year age group . This peak corresponds to the 
mcreased use of oral contraceptives in this age group. The increase is true 
only for Pill users and benign lesions. Vana et al in another study showed 
~at 40% of tumors were diagnosed in women exposed for five years or 
ess. ~emorrhage was most frequently associated with adenomas and almost 
exclusively confined to the oral contraceptive users. A significant number 
~fpatients present with signs of intraperitoneal hemorrhage and shock , the 
estons seeming most prone to rupture at or about the time of menstruation . 
A nun:tber of the reported deaths have occurred secondary to attempts 
at resection . For those lesions which are asymptomatic , the best and safest 
course would appear to be to discontinue the Pill , urge the patient to avoid 
:;gnancy and await spontaneous resolution of the lesion . Pregnancy, with 
effi resultan.t high levels of sex steroids , may have a particularly stimulating 
1ect. a~d mcrease the propensity for these lesions to hemmorhage . 27 ~dtvi~ua.l case reports have appeared in the literature , particularly in 
and et, linkin~ oral contraceptive use, some compounds containing mestranol 
Fo ?thers ethmylestradiol, with malignant liver tumors in young women. 
21 ri~stance, two cases of cholangiocarcinoma in women on the pill, aged ~- 2? years respectively , were reported. This malignant tumor has its 
An Incidence in the sixth decade, being very rare in the third. 28 · 29 
care· adde? ~isk factor in the development of primary hepatocellular 
Afri tnoma IS mfection with hepatitis B virus which is endemic in Asia and 
chil:~ ~evertheless this liver malignancy is rare among . women of 
nng age (15-40) in Singapore. However Chong-Jin Oon eta! from 
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the Hepaioma and Liver Study Group of Singapore General Hospit 
primary hepatocellular carcinoma in a 29-year-old woman wh 
on two different formulations of the Pill (both containing ethiny 
for seven years. They considered the administration of the Pil l 
have res11lted in the earlier development of primary hepatocellular 
in this case. 30 
The Pill and Malignant Melanoma in Australia 
reported 
ad been 
stradiol) 
1ay well 
1rcinoma 
Valerie Beral and her associates have reported on a case co rol study 
of287 women aged 15-24 years with malignant melanoma and 5 matched 
controls conducted in Australia . 
Their findings indicated that, after a lag of I 0 years , oral c 
use for a total of five years or longer was associated with a 50 
in risk . This relationship persisted after adjusting for a number 
confounding factors , including complexion , sunbathing activities 
and education. · 
raceptive 
increase 
· potential 
.ccupation 
Beral et al note that relative risk estimates reported by the i study and 
several others which considered long term use of the Pill , were the range 
of 1.4 to 4.4. While these relative risks were not large , they e re of the 
same order of magnitude as the relative risks for blond hair colo t RR = 1.6) 
or fair skin (RR=2.1), noted ·by them for Australian women oth these 
factors are widely accepted as being important determinants o f elanoma. 
In conclusion the authors state: ' ' If, as our data and that of otl rs suggest. 
a lag period of 10 years or more is involved , it may still be se'h .-a! decades 
before the effects of oral contraceptives on malignant melan ,rna can be 
properly evaluated . " 3 1 
The Pill and Cancer of the Cervix 
One of the most fascinating stories of modern medicine i~ the gradual 
unfolding of the epidemiology of cancer of the cervix. Wh ile ultimatelY 
linked with the intricacies of behavior (perhaps misbehavior would be the 
better word) of human beings in regard to sexual activity and the not· 
unexpected influence of sexually transmitted diseases, the Pi ll has managed 
to find its way into the labyrinth , together with the ubiqui tous ciagrette. 
While the epidemiological jig-saw is not yet complete, enough pieces have 
been fitted into the picture to provide a good idea of the general landscape· 
It is an ill wind that blows no one any good. We have to thank th_e ad~en: 
of the Pill for the tremendous stimulus it has provided to epidemwlogtc: 
research and the crop of outstanding researchers who have ri sen to 1 e 
occasion in elucidating its many ill effects and its occasional hea lth benef~s . . 
~he accompanying rise in_ sexually ~ransmi~ed d~seases ~as prov ided anot ~~ 
nch field for research w1th many mterestmg d1scovenes . All of whtch. 
pays one to reflect , has been an expensive ongoing exercise . Chasti~y rna ,: 
in the eyes of modern liberated humanity , be a very dull virtue . but tt co 
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effectiveness is undoubted. It also sets the standard in public health and 
preventive medicine. Its cost to the taxpayer is nil, in sharp distinction to 
the legacy of sexual liberation. While it may be cynically pointed out that 
it is simply a case of a virtue bringing its own reward, it should be considered 
worthy of a civic award - perhaps even a Nobel prize. 
The suggested solutions take no account of the possibility that the 
promotion of chastity may provide the answer. No, man 's ingenuity will 
find a way by producing some marvelous new polyvalent vaccine, dealing 
a death blow to gonorrhea and syphilis, as though they were as controllable 
as diphtheria and tetanus. Among the ranks of man 's brilliant modern 
rese~r~hers is waiting another Salk or Sabin who can produce a vaccine 
toehm~nate the villainous Herpes virus II and its partner in crime, the genital 
~~VIrus. Chastity, like modesty, is a term soon to be dropped from the 
d1cttonary as obsolete, belonging to the Victorian era of sexual suppression 
and frustration. Sexual liberation is here to stay , a much-venerated sacred 
cow. It is unthinkable that it be open to challenge. Yet all the findings point 
t~ sexual promiscuity as the culprit in the epidemic of pelvic inflammatory 
~tsease, of herpes genitalis, of cervical neoplasia and even of acquired 
Immune deficiency syndrome - AIDS. 
Up till about 30 years ago , mortality figures for endometrial and cervical 
~ancers were combined for statistical purposes. Only since that time has 
11 ~n possible to study cervical neoplasia in any detail. There are two 
pnnc1pal hypotheses considered in the etiology of cancer of the cervix : 
(I) the association of cervical. cancer with factors related to an early age 
at fi · 
•rst •~tercourse and first pregnancy. It proposes that d:1ring adolescence , ~ cerv1cal epithelial cells are especially vulnerable to carcinogens (the 
oppleson theory). 
0
/ 2> the association of cervical cancer with factors related to ~he multiplicity 
sexual partners, not only of the woman herself but also of her husband 
r:~po_sing that malignant change is induced by a sexually transmitted 
ectJon. Herpes virus type II , the cause of genital herpes , has been long 
:garded as the specific agent. 32 However, more recently , human papilloma 
lrus, responsible for genital warts , has been joined with the herpes virus 
as a cofactor. 33 
~nc_er o~ the uterine cervix is almost unknown in nuns . The list of ~ rruolog1cal factors associated with cancer of the cervix have been known 
~number of years. They constitute a formidable list indeed: broken 
act' _age, multiple marriages , extramarital sexual activity , premarital sexual 
ifk!IVJty, early age of first marriage, early age of first intercourse , multiple 
rnu~~~ abortions, illegitimacy, multiple sexual partners of the woman, 
se"J e sexual_ partn~rs of her husband, history of prostitution , history of 
On h transmitted d1sease , low socio-economic status, and urban residence. 
rest . 1. e other hand, common denominators of the low risk groups are: 
~ct•~e codes of _se~ual conduct (chastity) , and religious endogamy , e.g ., 
A. w 0 marry Wtthm their religious faith , particularly of the Jewish faith . 
study of 750 Taiwan prostitutes by Sebastian et a! provided strong 
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support for Coppleson' s theory . 34 Their women su.bjects did ~ t 
trade until they were aged 18 . They showed a low y1eld of cerv H 
of 10 .7 per 1 ,000, indicating that it is sexual activity du~ing th 
phase of active metaplasia which predi.sposes t? cervical d: 
neoplasia . Many authors feel that there IS a contmuui? betwe 
and neoplasia , including invasive cancer of the cerv1.x. 
A new hypothesis of the etiology of cancer of the cervix has b 
by Skegg et al , underlining the importance of the ~ale f~ctor. 3 
point out that concentration on female sexual behaviOr fatls to e 
epidemiological features of cervical cancer, e.g :: . 
tart their 
Jysplasia 
iolescent 
[asia and 
dysplasia 
proposed 
1e authors 
tin several 
~ re female 
valued in 
1. the extremely high incidence in parts of Latm Amenca 
chastity before marriage and fidelity within marriage are hi[ 
some of these societies; 
2 . the large decline in mortality in many western co~ntrie ' e r the past 
half century or more which started long before screenmg p r ams began 
in 1965; 
3. the low risk in Jewish women; 
4. the association with cigarette smoking, which appears to l 1dependent 
of sexual risk factors, and 
5. the possible association with oral contr~cepti.ves. 
transmitted 
be of great 
la-in-situ in 
·sk increased 
he husbands 
If cancer of the cervix is eaused by . an mfect1ous age 
venereally the sexual background .of each ma~e partner ~~ 
importance. In one study of cervical dysplasia and car~n 
women who claimed to have had only one partner, the relat1v 
with the number of sexual partners their husbands reporte 
of affected women were also more likely to have had vene J disease, to 
have visited prostitutes and to have had affairs during m ; tage. 
In some Latin American societies, women are expected tt ave ~nly one 
h S h ehavwr was partner , whereas their husban?s. m~y ave ~an~ · uc : vors the 
characteristic of European societies m th.e V1cton~n ~ra .d. fa h have 
flouri shing of prostitution . Cali in Colombia and Recife m F tz!l bot . d 
f · · h ' h •r than Umte incidence rates of cervical cancer 01.1r to s1x times 1g t fi . cy 
Kingdom registries . It has been suggested that this could be c' uc ~o de !CI~n en 
of Vitamin A in South American countries. Howev~~ prostl'Ution h~s ;en 
a prominent feature of life in these countries and VISits to r .. othels . Y their 
may account, at least in part , for the high risk of cervical ..: ancer 10 
wives. . . . . h terized the 
The decline in mortality m cervical cancer, which has c arac b ween 
· · d t · men born et , present century' was mterrupted by mcrease ra es m wo . . e 1939-4' 
1911 and 1926 who spent part of their early adult lives dunng th d ' ' the 
war when th~ incidence of gonorrhea was high. This sugge~te es in 
Pre;ence of an infective agent which was increased by the c angh , 36 
. h b b d its aftermat · 
customary sexual partnerships broug t a out Y war ~n f sexual 
The general decline in mortality may involve changmg patt.erns 0 mbled 
behavior in men from Victorian and Edwardian patterns which rese ctard· · 
. . h h · " double stan those of contemporary Latm Amenca w ere t ere IS a 
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of sexual morality with much resort by men to prost itutes . 
In contemporary western society, the so-called permissive society, marked 
by increasing premarital sexual activity , particularly in women -both men 
and women tend to have several sexual partners. C ervical cancer mortality 
rates in young women have begun to rise again, at least in Britain and New 
Zealand. 
Another important etiological factor is related to the husband's occupation. 
There is a high mortality in the wives of men in spec ific occupations which 
involve travel and absence from home. There is also evidence which suggests 
that, if cervical cancer develops in a man ' s first wife , his subsequent wife 
may be at an increased risk. This might reflect transmission of a virus from 
the male , the identity of which virus is as yet unknown . 
Malignant disease is the most common cause of death in women aged 
25 to 50. While the immediate effect of the Pill on vascular disease was 
~ccepted fairly quickly , the increased risks of malignant disease and mental 
lll.ness have taken longer to be acknowledged and quantified by large scale 
tnals. 37 In the Oxford/ F.P .A. contraceptive study of 17 ,032 women aged 
between 25 and 39, there were twice as many deaths from neoplasms (25.3) 
as compared with circulatory disorders (12 .3). 38 , 39 
A 1978 report of thi s same study was entitled "Neoplasia and dysplasia 
0~ the cervix uteri and contraception: a possible protective effect of the 
~1aphragm". Sixty-five of the women developed cervical neoplasia , the 
mcidence rate in diaphragm users being 0 . 17 per I ,000 women years of 
?bservation as against the much higher rates of0 .95 in Pill users and 0.87 
10 those fitted with an I. U. D. All s ix women who developed invasive cancer 
h~d been using the Pill at the time of entry to the study . For the first time, 
~Iga~ette smoking was reported as a major ri sk factor in cervical neoplasia 
In th1s study. Al so, as compared to Pill and IUD users , diaphragm users 
were less likely to have had coitus at an early age and had had ntaterially 
fewer sexual partners . 40 
ln. 1980, Harris et al showed that the ri sk of cervical dysplasia or 
ca.rcmoma-in-situ increased with duration of Pill use, while the risk decreased 
w;th prolonged use of barrier methods . They also found that the number 
0 pa~ners exerted effects independently of age at first intercourse . Cigarette 
smok~ng once again showed up as a significant risk factor. 41 
Meissels et al, in a study of French Canad ians in Quebec , found in 2,017 
~omen with mild and moderate dysplas ia highly significant correlations 
fl tween early age at first coitus and oral contraceptive use . When corrected 
or age at first coitus, there was a significant excess of dysplasias in Pill 
~~~r Dys.pla~ia of ~he u~erine cervix beh.aves epidemiologica~ly like 
w dnoma-m-s1tu and mvas1ve squamous carcmoma, they stated-m other 
atf~ s, es~entially as a venereal disease . It remained to be seen whether 
si rplaslas form one continuum or whether there are two morphologically 
ffil ar. but biologically distinct forms of dysplasia - one more frequent, ~~ssmg SJ?Onta~eously; the other relatively rare , progressing to carcinoma-
u and mvas1 ve carcinoma of the cervix. 42 
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Stern et al, in a study of 300 women with cervical dysplasia >mpared 
to 300 with negative smears, found that those using the Pill had increase 
in both severity of dysplasia and in the incidence of co!".version to ·cinoma-
in-situ. The probability of progression from dysplasia to cancer ' ill users 
was 0.3 after seven years, compared with 0.05 in non-users . 
In the American Walnut Creek study of 16 ,638 women, 6 1 
the Pill while 50 % of those aged 50 to 54 had taken estrogen 
cause of the 170 deaths were malignant neoplasms ( 45 %), comr 
15 % of deaths due to vascular causes. Cancer of the cervix was 
ad used 
e major 
d to only 
nificantly 
increased for those under 40 years of age. Malignant mela nas were 
significantly increased as was lung cancer. in Pill users who 1ked . All 
six cases of urinary tract neoplasms and SIX of the seven th) J cancers 
occurred in users. 
Registration rates for carcinoma-in-situ have increased fro n 
per 100,000 between 1965 , when registration began , a~d 197 ~ 
increase in new cases is in the 15- to 24-year-olds (ten times) 2 
(five times) and in the 35- to 44-year-olds (twice). These 
considerable increases in the incidence of both breast and ce 
since the early 1960s when the Pill was introduce~ . 
" replacement" therapy became fashionable. The larg~st ~nc 1 
15- to 24-year-olds who, although they still have a low mc~de t 
have only recently become the main age group to start usmg 
age group has a risk of double exposure to exogenou~ h01 
mothers may have taken them during pregnancy or lactatiOn (1 
Pill or Depo-Provera) . 44 
.~6 to 15.2 
he largest 
134 group 
.1 res show 
cal cancer 
. estrogen 
, e is in the 
of cancer, 
..: Pill . This 
mes . Their 
the mini-
. , 
·oup of318 
fertility due 
tctors which 
A very recent study by Holst and Abyholm45 lo~ked at a 
women with tubal infertility in Norway. Women w1th tubal 
to pelvic inflammatory disease tend to have many of the risk 
characterize women who develop cervical neoplasia. Th i rt ~ nne ~f th.ese 
women (9. 7 %) had dysplasia of varying degree or ca re ' ~a-m-sl~ 
Fourteen (4.4%) had severe dysplasia or carcinoma-in-situ Th1s was 
times the national average for women in the age group f2t' 39). Amon~ 
200 unselected infertile controls, one patient had moderat and one sevher 
• & ·1··. The aut ors dysplasia. Both of these were found to have tubal m.ertl 1t • . 
conclude therefore that women with tubal infertili ty represe~t as 
' ' f e rous lesiOn comparatively high risk group for the development o precanc 
of the cervix. nd 1977 
In the U.S.A. the use of the Pill fell by 25 % between 1974 a hod 
but increased by 25% in the U .K. 46 The Pill is the contraceptive me~ of 
of choice for young unmarried girls who are now at much grea~~ ~~~ned 
becoming promiscuous than they were 2.0 year_s ago and havmgmatbabies. 
pregnancies , abortions , sexually transmitted disease and abnor a rs 
The prestigious medical journal, Lancet, is noted for the number ofp ~of 
d fu · th media becaus it has published which have arouse a ror ~n .e h Lancer 
consistently dramatic discoveries concerning the Ptll 's Ill effects. T ~ Prof. 
on Oct. 22, 1983 , published not one, but two such papers, one Y 
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M.C. Pike and his group in Los Angeles47 on breast cancer and the Pill 
and the other by Prof. Martin Vessey and his colleagues on the possible 
adverse effect of the Pill in cervical neoplasia. 48 The reaction of the media 
and of medical leaders in the field of family planning to this ' 'bombshell'' 
was characteristic - one of startled dismay and , in the case of many of the 
doctors , disbelief. In fact both studies confirmed evidence which had been 
mounting for some time . 
As these papers were published when mine was well advanced I shall 
deal with them both at this point as what one might call a Stop Press item. 
The Breast Cancer Study 
~ike and his colleagues carried out a case-control study of 314 breast cancer 
patients aged less than 37 years at diagnosis and 314 individually matched 
controls to assess the influence of the Pill on the risk of the disease. They foun~ t~at long term use of the Pill , before age 25, of the combination type 
c~ntam1?g a "high" content of the progestogen component, was associated 
Wtth an mcreased risk of breast cancer. The relative risk was approximately f~ur after five years of such use , and nine cases and no controls had used 
Pills o~ this type for more than six years before age 25. 
Prev10us studies of this type had few data on long term Pill use before 
the .first full-term pregnancy. 
Pike et al postulate that , as the combination Pill suppresses ovulation ~ . ' 
ere IS a lack of rupture of the s·urface of the epithelium of the ovary and, hen~e, a decrease of mitotic activity in this area where ovarian cancer arises. 
A Similar lack of activity characterizes the effect of the Pill on the 
enfdometrium, the peak of mitotic activity taking place in the follicular phase 0 the normal cycle . 
1 In the breast , the reverse occurs, mitotic activity reaching a peak in the 
uteal phase due to the effect of progesterone acting in combination with 
estrogen. Combjnation oral contraceptives , with their mixture of estrogen ~rogestogen, may therefore stimulate breast tissue mitotic activity. The ~- .r the estrogen and progestogen content of the Pill , the greater the mitotic 
at IVJty and hence the increase of risk of breast cancer. If Pill use begins 
the an early age, when long and frequently anovular cycles are still common, 
fi n the longer the time and the more intense the stimulation before the 
Irst pregnancy. 
e Th~ authors point out that the use of the Pill during similar cycles 
. xpenenced during the pre-menopausal period is also associated with 
Increased risk of breast cancer. · bot~s an interesting sequel to Professor Pike 's study , a letter signed by 
IIUbr Prof~ssors Vess~y ~nd Pike as well as two other researchers and 
fo IShed m the followmg 1ssue of Lancet, announced that they were joining 
in rces to conduct a large case control study of breast cancer and the Pill 
Young women in the U.K. 
ember, 1985 
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The Neoplasia of the Cervix Study 
The Oxford-based group carried out a 10-year ~ollowup of 
women who entered the Oxford-FPA contraceptive stu_d_y wl 
Pill and 3,154 parous women who entered the ~tudy whlie u 
to determine the incidence of biopsy-proven cervical neoplas1<. 
of invasive cancer , which were of squamous _typ~, occurred 
the oral contraceptive group. Both carcinoma-m-s_Itu and cer~ 
also occurred more frequently in this group than m those usr 
incidence for all three forms of neoplasia combined, rose fran-, 
woman-years in those with up to two years Pill-use to 2 .2 per 
years in those with more than eight years Pill use . There wa~ 
among IUD users , where the rate remained c~nsta~t , aroun 
woman-years. The great majority of cases of mvas1ve cancei 
by means of cervical sme~rs. The agwegated data for all f01 
neoplasia provided considerable ev1d~nce for an assoCiat 
contraceptive use ~ a disturbing find1?g. . 
Vessey and colleagues had already pomted out fro~ result, 
FPA study published in 1978 that the use of the ~mphrag . 
protection against cervical neoplasi~ and that all SIX warne 
in whom invasive cancer of the cervix had developed at that 
using the Pill. 4 9 Hence , women using a ~iaphragm .ar::: un 
a comparison group in view of the relatively low mc1der 
neoplasia among them. . 
Unfortunately data about age at first intercourse and nu n 
partners were not collected f~r the women .under study . W ( 
durations of Pill use were slightly more hkely to be hea\ 
to have married and had their first full term pregnane~ at an 
women with short durations of use . Similar small d1ffere• 
8 parous 
·1sing the 
an IUD, 
! 13 cases 
vomen in 
dysplasia 
•J Ds . The 
per I ,000 
;O woman-
·mch trend 
per I ,000 
1·e detected 
of cervical 
with oral 
the Oxford 
, ight offer 
n the study 
e, had been 
,sfactory as 
of cervical 
rs of sexual 
·n with long 
makers and 
1rly age than 
.:s were al so 
apparent in the IUD group. . . . ·· fie estrogen 
Cervical neoplasia was not found to be associated w1th a sr ~ ' h p·ll. 
. I d f t or bl •Jd oft e I or progestogen or with any part1cu ar ose o es . rogen . h oral 
A large number of epidemiological studies conce n~d Wldt orne 
· f · 1 1 · have been 1 •tollshe · 5 contraception and the nsk o cervica neap asia . . ·.· . . n between 
showing negative results while others showed a positive asSOL l:lt iOI -term 
· d' · 1 d d en tew ong risk and duration of use . The negative stu Ies me u e v • been 
users of the Pill. In the Oxford group study, no association Wl~~d ha~~ even 
apparent if the data had been restricted to women of up to -
72 - months of exposure . . ak1·no a I t . u ~ ' IS 01 e The possibility that prolonged ora contracep 1ve - ~.:. . vix and 
contribution to the steadily rising death rates from cancer. of the .ce~ gland 
the incidence of invasive cervical cancer and carcino~a-m- sJ t ~:sentrends 
in women under 34 in the last decade, should be borne m mmd. . sexual 
. b 'b bl t chanoes In have generally been considered to e attn uta e o e 
behavior. . . . an unfavorable 
It is uncertain by what mechamsm the Pill m1ght have 
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influence on the risk of cervical neoplasia , but cervical tissues are known 
to be responsive to the influence of contraceptive steroids . Furthermore 
if the Pill d~es indeed speed up the "transit time" from cervical dysplasi~ 
to m~re senous neoplasic lesions as described by Stern et al , 5o this might 
explam why the Oxford group observed a substantial relation between Pill 
use and invasive cancer. The authors conclude that their data offer 
cons~derable support to the view that long-term use of the Pill may increase 
the nsk of cervical neoplasia , while not overlooking the influence of sexual 
factors. They recommend that women who have accumulated more than 
say, four years of Pill use should regularly have cervical smears to enabl~ 
serious disease to be detected and treated while it is curable. 
. Now, almost two years later , the significance of the study by Vessey and 
h1s colleagues remains , although attempts have been made to discredit it 
on the grounds that it did not identify age at first intercourse and numbers 
of sexu.al partners. Early age at first intercourse is recognized as an important 
factor m the etiology of neoplasia of the cervix , while the sexual hi story 
of male co~sorts has also come to be accepted as of considerable significance. 
The possible confounding effect of cigarette smoking , which was unknown 
as a co-factor in cervical neoplasia at the time the Oxford study began, has 
also been put forward to weaken the impact of its findings. 
Further evidence in support of a Pill-cervical neoplasia hypothesis has 
come from. a ~HO study , largely based on women in developing countries who~ prehmmary findings show an increase in the relative risk for invasive 
c~rcmoma of the cervix in women who have ever used the Pill. The relative 
nsk of .1. ~ 9 for ever-users increased to I . 53 after five years of Pill use . 5 1 
The .hm1ted levels of screening procedures for cervical cancer in developing ~ountnes was considered important as it overcame the problem of a bias 
10 favor of early diagnosis in Pill-taking women .who tend to make frequent 
use of these procedures in countries where they are more readily available . 
A ~nly 31% of the cases gave a history of multiple sexual relationships . 
H s 10 the Oxford study, information on cigarette smoking was not ~ollected. 
ow~ver the researchers pointed out that this is unlikely to be an important ~ndtnbuting factor. Cigarette smoking is uncommon among the older womeri In evelo · · Th ~mg count.nes who made up the bulk of those studied in this survey. 
1 e Weight of evidence from what are now numerous studies dealing with io on~ed use of the Pill and the development of neoplasia of the cervix 
hosconsiderable. The implication of this for women currently using the Pill Wever is h . . . , 
e ' somew at uncertam because the findmgs are based m part on ~pos~re to preparations which contained higher doses of estrogens and 
ogest_ogens than many products now in use . 
the A~~Jth the findings showing the cardiovascular risks associated with taking 
stUd III, efforts ~a~e been made to undermine the findings of this WHO 
in t~ ~y em~has1zmg the importance of cigarette smoking as a co-factor 
lhe Pill :usatiOn of cance~ of the cervi~. ~~ seems that th~ protagonists of 
ttl ould have us believe that the Pill 1s harmless and 11 1s only a matter "~ persu d' 
a mg women not to smoke. There does not appear to be any doubt , 
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however, that cigarette smoking and taking the Pill are a ~ tty lethal 
combination. 521 53 
Smoking and Cervical Cancer 
An association of cigarette smoking and cervical neoplasi ::• 
been recognized . A study by Trevathan et al in the U.SY has sl· 
smoking to be significantly associated with carcinoma-i r 
dysplasia and mild to moderate dysplasia with relative risks o 
2.4 respectively. Cumulative exposure to cigarette smoking 
by pack-years smoked) was strongly related to risk of the 
Women with 12 or more pack-years of exposure had relative 
10.2 and 4.3 respectively for the three conditions , with some 
the risk was greatest in women who began smoking in theit 
years. 
ts recently 
m cigarette 
tu, severe 
.6, 3.3 and 
; measured 
.:onditions. 
ks of 12 .7, 
idence that 
.rly teenage 
ous studies. 
of cigarette 
the cervical 
Generally the results of this survey support the data from pt 
It is suggested that cervical cells may be exposed to compon 
smoke that are absorbed into the blood and then secreted r 
epithelium. 
making and 
ttial , role of 
Jal partners. 
, 1e metaplasic 
.., of cigarette 
vably related 
The possibility of a causal association between cigarettt 
cervical neoplasia does not exclude the possible, or even e: 
other factors such as herpes simplex type II and multiple s• 
Perhaps the cervical epithelium, especially while undergoinf 
changes of puberty, is particularly sensitive to the carcinog, 
smoke . Alternatively a systematic effect of smoking , cone 
to vitamin A metabolism , could be the mechanism. 
By way of conclusion I could do no better than to quote 1 ->m the JAMA 
editorial on the subject of smoking and cervical cancer : . k 
"Cervical carcinoma in situ is a disease of young w men. The ns 
imparted by smoking is especially large for young women iv~n that ~he 
treatment for this disease may result in sterility it is obvious that m addtuon 
to jeopardizing their lives , smoking has resulted in an inability to bear 
children for thousands of women. " 55 
Conclusion 
. · h d d ital cancer With the news m 1970 that DES m mothers a cause gen . . f an 
in their daughters the scenario was set for the eventual recogmtwn ° e 
association betwe~n the Pill and cancer. By the mid 1970s, the occurr~n~n 
of new growths of the liver, albeit mostly benign , had already e
10 discovered . These were related , not surprisingly , to length of exposure 
the Pill. · vered 
About the same time, the news that endometrial cancer had been dtsco gen 
in women taking sequential oral contraceptives containing high dose esdtro .. aJ 
· d . t with ra\• 
and a weak progestogen, demethisterone, caused the tmme ta ~ that all 
of Pills of this type from the market. However 1t was rea lized 
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estrogens seemed to increase the risk of endometrial cancer, irrespective 
of their formulation or mode of administration. 
By the late 1970s, the etiology of breast and cervical neoplasia had become 
much clearer. The work of Pike and Passenbarger and their colleagues 
highlighted the possible effect of the Pill in the cause of breast cancer. 
Although large epidemiological trials appeared to show that the Pill reduced 
benign breast disease, many clinicians gained the opposite impression. As 
time went by, more women entered long-term categories of Pill-taking , or 
even just aged to the point where carcinogenic agents could exert their effect. 
The most recent findings of Professor Pike's research put the spotlight 
square'Iy on women who had taken high potency progestogen Pills from 
an early age, drawing attention to the concentration of the Pill ' s carcinogenic 
effects in adolescence and early adulthood . They also showed that 
progestogens, as well as estrogens , had carcinogenic potential. 
The rapidly rising incidence of cervical neoplasia in young women , at 
a time when mortality from this disease in older women was declining , 
worried the epidemiologists. The etiology of cervical cancer is complex 
and multifactorial , involving such factors as early commencement of 
intercourse, multiplicity of partners who themselves may have been 
promiscuous , viral infections , with Herpes virus II and the Papilloma virus 
acting as cofactors ; and now the recognition of an association between 
cigarette smoking and cervical cancer . Meanwhile , the Pill during the late 
1970s had entered the list , gradually establishing its claim to be recognized 
as an important etiological factor. 
Finally, Vessey and his colleagues from Oxford confirmt>d the findings 
of others . As the wncet editorial said , in commenting on their recent paper: 
"The relation reported by them and others of an increasing incidence of 
cervix cancer with increasing duration of oral contraceptive .use is strong 
and consistent and the progression of dysplasic lesions to in-situ carcinoma 
seems to be accelerated by the Pill '' . 56 
The effect of the Pill in causing thrombo-embolism, stroke and heart 
a~cks, together with its disturbance of lipid metabolism, are well known. 
Cigarette smoking, although the mechanism of its action is obscure, is clearly 
recognized for its synergistic action in increasing the incidence of cardio-
vascular pathology in women on the Pill . It is of more than passing interest 
that cigarette smoking has now taken its place as a contributing factor in 
lleoplasia of the cervix. It remains to be seen whether there is a similar 
synergism of action with the Pill in this area . 
That the Pill could theoretically be an important cause of immuno-
~ression offers an interesting area for research in the immediate future . 
Ellen Grant has said: "Most women who are allergic to the 20th century 
~e previous Pill users . " 57 The Pill ' s disturbance of liver function could 
lllterfere with enzyme removal of mutagens and carcinogens. 
The responsibility for the harmful effects of prescribing the Pill for 
adoleseents needs to be sheeted home to those in our community who openly 
and consistently advocate it on the grounds of being " realistic" towards 
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the reeds of the young. It seems that, to them, the ultimate evil 
whi'h is to be avoided at all costs, whatever the conseqw 
advocates feel that parental rights should be overridden and t 
floUled, twisted or changed; that the young must have thei r 
it now , unrestricted , but always " protected" against pregna· 
is time , in the interests of the health of the women of our n 
long the guinea pigs of the oral contraceptive industry, fo r 
of this disastrous policy. 
The Centres for Disease Control Cancer and Steroid He 
Oral Contraceptive Use and the Risk of Endometri 
(lAMA 1983 . 249. pp. 1600-1604) 
1regnancy 
~s. Those 
law either 
and have 
. Surely it 
1n, for too 
eappraisal 
lOne Study 
ancer 
This study showed a protective effect for women 1 had used 
combination oral contraceptives. (OC) for at least 12 mont h heir relative 
risk being 0.5 that of never users. The protective effect w: nost notable 
for and largely confined to nulliparous women, whose ri .:as only 0.4 
that of nulliparous never users. Thi s has not been previo y reported. 
However , users of sequential OCs and all other OCs wer .t greater ri sk 
of endometrial cancer developing than never users , with r, rat ios (RR) 
of 2. I and I . 8 respectively . It appears that at least six day. ( progestogen 
treatment per month are necessary for it to exert its protecti d"fect agawst 
the carcinogenic effects of the estrogen of the Pill. ld 
The authors estimated that 39,000 women with endometr: : cancer wo~ 
be diagnosed in the U.S. in 1982 with 3,000 deaths, th .. ; J isease havwg 
the th.ir? highest inc.idence of all cancers. It was considen ' that more t~ 
40 million women m that country have used OCs. Appr ,Jmately 2. f 
potential new cases of endometrial cancer would be avcn L·d by the use 0 
combination OCs in 1982 , according to the authors of the report. 
The Centres for Disease Control Cancer and Steroid Hormone StudY 
Long-Term Oral Contraceptive Use and the Risk of Breast Cancer 
(lAMA 1983 . 249. pp. 1591-1595) 
. l b ore than The authors of this report state that OCs have been useu Y m er 
25 million women in the U.S . and I 50 million world wide. Breast ~~~se 
is the leading cause of cancer mortality among women in the U. S .. the IS 
affecting 7% of American women. 
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Most pu?lished studies of the effects of OC use on breast cancer were 
conducted m the early 1970s and hence were unable to look at the influence 
of long-ter.m OC use or the delayed effects of OC use on the risk of breast 
cancer, satd the authors. 
This study reports the initial 6.months of a 25 month study based on data 
for 689 women with newly diagnosed breast cancer and 1,077 controls. 
'f?e women were aged 20 to 54. Those with breast cancer, when compared 
Wt~h controls , were more likely to be nulliparous, be older when their first 
child was .born, have a history of breast cancer in first degree relatives 
(mother, sts~er, daughter) and a history of benign breast disease. They were 
also more likely to be premenopausal. 
c Compared with women who never used OCs, the relative risk of breast 
,:~ce~ for women who used the Pill for at least one month sometime in 
et~ Itves was 0.9 . The duration of OC use, up to II years or more did 
not mfluence a woman's risk of breast cancer. ' 
A lack of association between OC use and the risk of breast cancer was 
not.ed for women of all ages studied . Even long-term use (II years or more) 
:~tch beg~n more than 15 years ago, did not alter the risk . Women who 
1./wthe Ptll before their first full term pregna.ncy showe? a risk ratio of 
mat ~en c.ompared to controls . The authors dtd not constder this to be a 
bec:~~ally mcr~a~ed risk , but suggested fu~the~ analy~es of such cases -
b e of thetr tmportance . Use of the Ptll dtd not mcrease the risk of 
freabst cancer among women with benign breast diseas~ or a family history 0 reast cancer. 
b The authors make no claims of any cases of breast cancer being averted 
Y use of the Pill . 
The Centres of Disease Control Cancer and Steroid Hor.mone Study 
Oral Contraceptive Use and the Risk of Ovarian Cancer 
(lAMA 1983 . 249 . pp . 1596-1599) 
Ovarian cane . k h fi · 
wome . er ran s as t e ourth Ieadmg cause of cancer mortality among 
will n 10 the U.S . An estimated 18,000 cases and II 400 attributable deaths 
occur among A . . 1983 ' . w·u mencan women m . Almost one-thtrd of the cases a~ro~c~r among women aged 20 to 54 years. Pregnancy appears to exert 
can ecttve effect, several studies having noted an increased risk of ovarian ~er among women of low parity . 
lbe fie authors report their analysis of ovarian cancer data collected during 
diagntrst diO months of a study of 179 women, aged 20 to 54 with newly 
ose ovarian d · . ' . Co . cancer, compare to I ,642 women wtth mtact ovanes. 
lobe mpared Wtth controls, women with ovarian cancer were more likely 
llld t~ohunger th~n 30 years of age, to have never married or been pregnant 
The ave a dtagnosed infertility problem. 
~elo a.uthors found that the age-adjusted relative risk of ovarian cancer 
Pmg for ever-users compared with never-users was 0.6, the risk 
. 1985 317 
decreasing with increasing duration of OC use to 0.4 in woP 
used the Pill for five yea rs or more. This lower risk appea 
long after OC use ceased . 
who had 
o persist 
The authors consider that whether ovarian cancer is c 
" incessant ovulation " of the nulliparous woman or by the altc 
that high levels of circulating pituitary gonadotrophin-, 
development , both are consistent with a protective effect of ' 
both inhibits ovulation and suppresses gonadotrophin rete; 
d by the 
tVe theory 
Jmote its 
' ill , which 
They estimate that the incidence of ovarian cancer in w 
might be about 30 % highe r if women had never used OCs . 
about I , 700 cases of ova rian cancer in this age group wii 
1983 by the use of the Pill . Further investigation of the c 
ovanan cancer and its re lationship to OCs is clearly wa 
opm10n . 
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